📰 Stop Significant News

Stop Significant News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Stop Significant. Real-time updates on events, politics, business and more.

Five Bipartisan Pharma Patent and Pricing Bills Shared in Senate

February 14, 2023

During the February 9, 2023 Executive Business Meeting, Senate Judiciary Committee reported Interagency Patent Coordination and Improvement Act of 2023, Prescription Pricing for the People Act of 2023, Preserve Access to Affordable Generics and Biosimilars Act, and more.

United States Trademark Office Human Services Senate Judiciary Committee Drug Administration Business Meeting

Source: natlawreview.com

Senate Judiciary Committee Pushes Pharma Patents and Pricing Bills Forward | Foley & Lardner LLP

February 14, 2023

It is hard to predict whether a given bill will gain traction, but when the Senate Judiciary Committee reports out five bipartisan bills targeting pharmaceutical patents and pricing, it...

United States Trademark Office Human Services Senate Judiciary Committee Drug Administration Foley Lardner

Source: jdsupra.com

Biosimilars 2021 Year in Review | Fish & Richardson

January 12, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology...

New York United States District Of Columbia Samsung Bioepis Merck Seecertain Adalimumab Eli Lilly

Source: jdsupra.com

Grassley, Klobuchar Reintroduce Bipartisan Bills to Reduce Prescription Drug Costs, Promote Competition – Mix 107.3 KIOW

May 1, 2021

Sens. Chuck Grassley (R-Iowa) and Amy Klobuchar (D-Minn.) reintroduced the Preserving Access to Affordable Generics and Biosimilars Act and the Stop S

United States Chuck Grassleyr Iowa Amy Klobuchard Minn Drug Administration Chuck Grassley Amy Klobuchar

Source: kiow.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation